Telix Pharmaceuticals American Depositary Shares (TLX) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	206.72M	206.72M	238.68M	238.68M
Cost of goods sold	110.68M	110.68M	122.86M	122.86M
Cost of revenue	110.68M	110.68M	122.86M	122.86M
Research and development expenses	44.83M	44.83M	61.91M	61.91M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	47.93M	47.93M	53.51M	53.51M
Operating expense	92.02M	92.02M	92.64M	92.64M
Total operating expenses	202.70M	202.70M	215.49M	215.49M
Operating income	4.02M	4.02M	23.18M	23.18M
Other non operating income	-7.23M	-7.23M	-7.45M	-7.45M
EBT including unusual items	-215.00K	-215.00K	14.62M	14.62M
EBT excluding unusual items	-6.75M	-6.75M	13.16M	13.16M
Income tax expense	2.20M	2.20M	-4.54M	-4.54M
Effective tax rate	-1,023.95%	-1,023.95%	-31.05%	-31.05%
Other operating expenses	-745.50K	-745.50K	-22.79M	-22.79M
Net income	-2.42M	-2.42M	19.16M	19.16M
Net profit margin	-1.17%	-1.17%	8.03%	8.03%
Earnings per share	-	-	-	-
Interest and investment income	1.10M	1.10M	1.14M	1.14M
Interest expense	-3.78M	-3.78M	-3.71M	-3.71M
Net interest expenses	-2.68M	-2.68M	-2.57M	-2.57M
Depreciation and amortization charges	-	-	-	-
EBITDA	7.09M	7.09M	28.66M	28.66M
Gain or loss from assets sale	-	-	-	-

Ask anything